2m 2m 2m 2m 2m 2m 2m
RELMADA THERAPEU (RLMD)
NASDAQ
$4.56+$0.04 (+0.97%)
Price as of Sep 11, 2026 7:59 PM EDT- $482.1MMarket Cap
- 184.28%1-Year Change
- BiotechnologyIndustry
RELMADA THERAPEU (RLMD)
$4.56+$0.04 (+0.97%)
RLMD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.52 | ||
Change | +$0.45 (+11.06%) | ||
Open | $4.60 | ||
High | $4.65 | ||
Low | $4.29 | ||
Previous Close | $4.07 | ||
Volume | 2,629,279 | ||
30-Day Average Volume | 1,136,722 | ||
1-Week Change | 2.03% | ||
1-Month Change | 1.12% | ||
1-Year Change | 184.28% | ||
3-Year Change | 32.16% | ||
5-Year Change | -82.63% | ||
Fundamentals | |||
Shares Outstanding | 106.7M | ||
Total Assets | $219.1M | ||
Market Cap | $482.1M | ||
Enterprise Value | $470.8M | ||
Period: QTR TTM FY | |||
Revenue | -$204,552.00 | ||
Net Income | -$12.9M | ||
Free Cash Flow | -$9.6M | ||
EBIT | -$12.9M | ||
EBITDA | -$12.9M | ||
Net Working Capital | $211.6M | ||
EPS | -$0.11 | ||
Enterprise Value/EBITDA | -36 | ||
Enterprise Value/Revenue | -2,302 | ||
P/B | 2 | ||
P/E | -41 | ||
PEG | -1 | ||
Price/Free Cash Flow | -50 | ||
Price/Operating Cash Flow | -50 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 4 | ||
Last Split Date | 09/30/2019 | ||
Earnings & Revenue